Scientists at the Sagol Center for Regenerative Biotechnology, the Shmunis School of Biomedicine and Cancer Research, and the department of biomedical engineering at Tel Aviv University have generated ...

Chicago-based Amphix Bio has raised $12.5 million in seed funding to advance its experimental paralysis-reversing drug toward ...

For generations, paralysis from a damaged spinal cord has been seen as permanent. Once the nerves were injured, the signals carrying movement from the brain to the body were lost forever. But ...

ScientiFix, our weekly feature, offers you a summary of the top global science stories of the week, with links to their ...

A groundbreaking human trial has begun that could transform life for people with spinal cord injuries. The project, developed over three decades, uses a unique cell-based approach that scientists hope ...

Cedars-Sinai investigators have discovered a healing mechanism that could one day be harnessed to help treat patients with ...

In what is being described as a world-first, scientists in Israel have reportedly grown spinal cord implants utilizing tissue extracted from human volunteers. Those implants were then used to restore ...

A groundbreaking study from UC San Diego has identified Thiorphan, an existing drug, as a potential game-changer for spinal cord injuries. Researchers used advanced bioinformatics to discover its ...

The new organoids were grown in the lab for up to 40 days, and they mimicked the central nervous system of an 11-week-old human embryo. When you purchase through links on our site, we may earn an ...

Cats always land on their feet, but what makes them so agile? Their unique sense of balance has more in common with humans than it may appear. Researchers are studying cat locomotion to better ...

For the first time in the world, researchers from Sagol Center for Regenerative Biotechnology at Tel Aviv University have engineered 3D human spinal cord tissues and implanted them in lab model with ...